Form 4 for AVTR Avantor, Inc.
Accepted 2022-03-02 00:00:00 ET · period of report 2022-03-01 · accession 0001722482-22-000067 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-02 | 2022-03-01 | AVTR | Brophy Gerard | EVP, Biopharma Production | S - Sale | $34.47 | -2,027 | 136.2K | -1% | -$69.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-01 | S | D | 2,027 | $34.47 | 136,221 | D | — | — |